[HTML][HTML] Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer

L Xu, Y Ye, Y Sun, W Zhong, L Chi, Y Lin… - Frontiers in …, 2022 - frontiersin.org
Background: FNDC5 belongs to the family of proteins called fibronectin type III domain-
containing which carry out a variety of functions. The expression of FNDC5 is associated …

Clinical significance of serum type III interferons in patients with gastric cancer

H Zhao, N Dong, T Liu, P Zhang, Y Zheng… - Journal of Interferon & …, 2019 - liebertpub.com
Type III interferon (IFN) is a newly established IFN that shows roles different from those of
type I and II IFNs. However, the effect of type III IFN on the prognosis of patients with gastric …

[HTML][HTML] IRF6 is directly regulated by ZEB1 and ELF3, and predicts a favorable prognosis in gastric cancer

D Li, P Cheng, J Wang, X Qiu, X Zhang, L Xu… - Frontiers in …, 2019 - frontiersin.org
Interferon regulatory factor 6 (IRF6) acts as a tumor suppressor and controls cell
differentiation in ectodermal and craniofacial tissues by regulating expression of target …

IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells

L Cui, Y Deng, Y Rong, W Lou, Z Mao, Y Feng, D Xie… - Tumor Biology, 2012 - Springer
Pancreatic cancer is one of the most malignant diseases in the world. Interferon regulator
factor 2 (IRF-2), an interferon regulatory factor, has been known to act as an oncogene in …

[HTML][HTML] Increased IGFBP7 expression correlates with poor prognosis and immune infiltration in gastric cancer

Q Zhao, R Zhao, C Song, H Wang, J Rong… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Insulin-like growth factor binding protein-7 (IGFBP7) contributes to multiple
biological processes in various tumors. However, the role of IGFBP7 in gastric cancer (GC) …

[HTML][HTML] Clinicopathological correlation of insulin-like growth factor binding protein 3 and their death receptor in patients with gastric cancer

A Ansari, A Gheysarzadeh, A Sharifi… - Research in …, 2024 - journals.lww.com
Background and purpose: The insulin-like growth factor binding protein 3 (IGFBP-3) and its
novel death receptor (IGFBP-3R) have been exhibited to have tumor suppressor effects …

[HTML][HTML] IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins

X Xu, Y Wu, K Yi, Y Hu, W Ding… - … journal of molecular …, 2021 - spandidos-publications.com
Radiation is one of the main methods for the treatment of colorectal cancer (CRC) before or
after surgery. However, radiotherapy tolerance of patients with CRC is often a major …

[HTML][HTML] Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer

YJ Chen, SN Luo, L Dong, TT Liu, XZ Shen… - Journal of translational …, 2021 - Springer
Background Since interferon regulatory factor (IRF) family functions in immune response to
viral infection, its role in colorectal cancer (CRC) has not been inspected before. This study …

[HTML][HTML] Expression and critical role of interleukin enhancer binding factor 2 in hepatocellular carcinoma

S Cheng, X Jiang, C Ding, C Du… - International journal of …, 2016 - mdpi.com
Interleukin enhancer binding factor 2 (ILF2), a transcription factor, regulates cell growth by
inhibiting the stabilization of mRNA. Currently, its role has gained recognition as a factor in …

Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients

L Liu, Z Yang, W Zhang, B Yan, Q Gu, J Jiao, X Yue - Tumor Biology, 2014 - Springer
Increasing evidence indicated that insulin-like growth factor binding protein 7 (IGFBP7) was
regarded as a potential tumor suppressor in various human cancers, but its role in gastric …